Mitochondria-associated endoplasmic reticulum membrane (MAM): roles in innate immunity dysregulation Authors: Qingqi Zhang, Junyan Gao, Yiting Yang, Ping Guo, Huiqin Gao, Shuaiyong Zhao, Shuanglin Zhang, Yaping Shi, Guanxing Xie, Yutong Han, Hao Liu, Yunzeng Zou Published: 2026 ABSTRACT AbstractMitochondria-associated endoplasmic reticulum membrane (MAM), which serves as a signaling hub for interactions between the endoplasmic reticulum (ER) and mitochondria, dynamically coordinates innate immune processes by regulating calcium homeostasis, lipid metabolism, mitochondrial dynamics, mitochondrial protein modifications, and autophagy. MAM regulates calcium homeostasis to govern mitochondrial energy metabolism and inflammasome activation; maintains lipid metabolism for membrane integrity to support antiviral signaling pathways; controls mitochondrial fission and fusion dynamics, processes that are closely associated with mitochondrial DNA (mtDNA) release; regulates mitochondrial protein modifications to fine-tune the function of proteins localized at MAM; and facilitates the clearance of damaged mitochondria and leaked mtDNA through autophagy. Most critically, MAM dysfunction and innate immune dysregulation form a vicious cycle: immune activation disrupts MAM integrity, and MAM abnormalities exacerbate the release of mitochondrial damage-associated molecules, continuously driving overactivation of pathways such as inflammasomes and the cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway, thereby promoting the development of autoimmune diseases. This review synthesizes current literature on the molecular mechanisms by which MAM regulates innate immunity. We summarize how disruptions in MAM-mediated mitochondrial homeostasis contribute to innate immune imbalance. By integrating these findings, we highlight potential intervention nodes. This underscores the clinical relevance of targeting MAM in immune-related pathological conditions.Keywords: Mitochondria-associated endoplasmic reticulum membrane (MAM), Mitochondrial homeostasis, Innate immunity, MtDNA Introduction In addition to lymphocytes, host defense against pathogens involves numerous cells and factors collectively referred to as the "innate immune system" [1]. Pattern recognition receptors (PRRs) are receptor proteins that recognize pathogen-associated molecular patterns (PAMPs). PRRs enable specific identification of conserved structures on pathogen surfaces, such as bacterial lipopolysaccharide, viral double-stranded RNA [2]. Upon PRRs activation, complex signaling pathways are initiated, leading to the production of pro-inflammatory cytokines and antiviral factors [3]. Concurrently, dendritic cell maturation is triggered, inducing co-stimulatory molecules and enhancing antigen presentation [4]. The mitochondria-associated endoplasmic reticulum membrane (MAM) is a specialized contact microdomain between the endoplasmic reticulum (ER) and the outer mitochondrial membrane (OMM), characterized by a precise gap of approximately 10–30 nm [5, 6]. Its integrity relies on two critical components. First, physical tethering proteins-such as mitofusin 2 (MFN2) and the vesicle-associated membrane protein-associated protein B (VAPB)-protein tyrosine phosphatase interacting protein 51 (PTPIP51) complex-maintain a stable intermembrane distance through molecular bridging [7, 8]. Second, functional complexes-including the inositol 1,4,5-trisphosphate receptor (IP3R)-glucose-regulated protein 75 (Grp75)-voltage-dependent anion channel (VDAC) calcium transport axis and the phosphatidylserine (PS) transporter Oxysterol-binding protein 5 (ORP5)/Oxysterol-binding protein 8 (ORP8)-ensure the highly efficient exchange of metabolites and signaling molecules [9–11]. When MAM integrity is compromised, it inherently involves the disruption of these structural tethers and functional complexes. Pathological manifestations-such as an abnormally widened intermembrane gap, reduced expression of critical bridging proteins, or the dysregulation of calcium/lipid transport complexes-can severely impair ER-mitochondria communication [12, 13]. Ultimately, this dysfunction precipitates the aberrant release of mitochondrial damage-associated molecular patterns (DAMPs) [14] (Fig. 1). The association between mitochondrial-associated endoplasmic reticulum membrane (MAM) and innate immune responses. MAM stress and viral RNA can both trigger innate immune responses. Viral RNA is recognized by cytoplasmic Retinoic acid-Inducible Gene I(RIG-I) or Melanoma Differentiation-Associated protein 5(MDA5). Upon activation, they bind to mitochondrial antiviral signaling protein (MAVS) located on the outer mitochondrial membrane. MAVS aggregates to form signaling complexes, which activate downstream transcription factors including nuclear factor-κB (NF-κB) and interferon regulatory factor 3 (IRF3), induce the expression of type I interferons and pro-inflammatory cytokines, and initiate antiviral immune responses. In addition, Under oxidative stress, dysfunctional MAM induces increased mitochondrial membrane permeability, resulting in the release of mtDNA into the cytoplasm. Simultaneously, mtDNA oxidized by mitochondrial reactive oxygen species (ROS) is also leaked as oxidized mtDNA (Ox-mtDNA). Subsequently, these leaked mtDNA molecules function as damage-associated molecular patterns (DAMPs) and are sensed by multiple cytoplasmic pattern recognition receptors (PRRs), thereby activating three major innate immune pathways. Specifically, the cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway is triggered when cytosolic mtDNA and Ox-mtDNA are recognized by cGAS, leading to synthesis of cyclic GMP-AMP (cGAMP), activation of STING and TANK-binding protein kinase 1 (TBK1), phosphorylation of interferon regulatory factor 3 (IRF3), and ultimately induction of type I interferon production. Meanwhile, Ox-mtDNA activates the nucleotide-binding domain leucine-rich repeat and pyrin domain-containing protein 3 (NLRP3) inflammasome pathway, resulting in the cleavage of pro-caspase-1 into active caspase-1. Additionally, the absent in melanoma 2 (AIM2) inflammasome pathway is directly activated by cytosolic mtDNA, which also converges on caspase-1 activation. Active caspase-1 then processes pro-IL-1β and pro-IL-18 into their mature forms, interleukin-1β (IL-1β) and IL-18, thereby eliciting a potent inflammatory response. The image was generated with full licensed BioRender.com MAM coordination involves crucial cellular processes including calcium (Ca2+) signaling [15], lipid synthesis and transport [16], mitochondrial dynamics [17, 18], mitochondrial protein modification [19], and autophagy [20]. Given that the aforementioned processes are deeply intertwined with core events of the innate immune response-such as inflammasome assembly, type I interferon production, and the sensing of mitochondrial damage-the critical role of MAM as an intracellular spatiotemporal signaling hub is gaining increasing attention. Recently, several comprehensive reviews have elucidated the spatiotemporal dynamics of the MAM, underscoring its profound implications across metabolic, neurodegenerative, and cardiovascular disorders [21, 22]. Although recent literature firmly establishes the MAM as a highly dynamic communication hub, the critical pathogenic intersection between MAM structural integrity and the multi-tiered cytosolic PRR network remains largely underexplored. Our review distinguishes itself by centering on the vicious cycle that links MAM dysfunction to innate immune dysregulation. Specifically, we provide a targeted mechanistic framework that integrates five core axes: calcium homeostasis, lipid transport, mitochondrial dynamics, post-translational modifications, and autophagy. By applying this framework, we elucidate how MAM aberrations drive the pathological leakage of mitochondrial DAMPs, thereby fueling the overactivation of nucleic acid sensors (e.g., cGAS-STING, MAVS) and inflammasomes (e.g., NLRP3, AIM2) in immune-mediated pathologies. The discovery of MAM Initially, MAM was regarded as a contaminant from the ER during mitochondrial isolation procedures [23]. Its recognition as a specific structural complex commenced in 1956 with observations by Bernhard and Rouiller, who observed specific contact structures between the rough endoplasmic reticulum and mitochondria in rat hepatocytes under electron microscopy [24]. Subsequently, in 1959, Copeland and Dalton further revealed in specialized cells of the pseudobranch gland that the rough ER maintained precise spatial positioning relationships with mitochondria via tubular structures, although its function remained unclear [25]. In 1969, Ruby et al. proposed that contact regions between mitochondria and the ER might possess special functions, particularly related to protein transport [26]. In 1973, Lewis et al. achieved the first separation of cellular crude extracts containing MAM structural components [27]. In 1990, Vance successfully isolated a membrane structure termed "fraction X" from rat liver using gradient centrifugation, confirming its key role in lipid synthesis and transfer, and named it the "mitochondria-associated endoplasmic reticulum membrane" [28]. In 2006, Csordás et al. employed electron tomography to systematically measure the spacing at ER-mitochondria junctions, finding that the distance between smooth ER and mitochondria was approximately 10 nm, while that between rough ER and mitochondria was about 25 nm [6]. In 2011, Zhang et al. identified over 1000 MAM-resident proteins using mass spectrometry, revealing their multifunctionality [29]. Innate immune signaling pathways In innate immune responses, the cGAS-STING pathway, nucleotide-binding domain leucine-rich repeat and pyrin domain-containing protein 3 (NLRP3) inflammasome, and absent in melanoma 2 (AIM2) inflammasome constitute a critical pattern recognition network that collaboratively senses PAMPs and DAMPs. Furthermore, mitochondrial antiviral-signaling protein (MAVS) serves as a pivotal adaptor in the innate immune response, initiating antiviral signaling cascades following the cytosolic sensing of viral RNA [30]. The cGAS-STING pathway The cGAS-STING pathway detects cytosolic double-stranded DNA (dsDNA), including viral DNA or host-derived DAMPs like mtDNA, via cGAS [31]. cGAS synthesizes the second messenger 2',3'-cGAMP, which activates the ER-resident protein STING. STING recruits TANK-binding protein kinase 1 (TBK1) to phosphorylate interferon regulatory factor 3 (IRF3), driving type I interferon expression and antiviral immunity [32]. During antiviral immune responses, TBK1 phosphorylates nuclear respiratory factor-1 (NRF1) at Ser318, thereby suppressing its transcriptional activity, reducing mtDNA release, and preventing excessive activation of innate immunity [33]. STING activation promotes lysosomal biogenesis by activating transcription factor EB (TFEB), thereby potentiating the cell's ability to clear cytosolic pathogens such as DNA, bacteria, and viruses [34] (Fig. 1). The NLRP3 inflammasome The activation of the NLRP3 inflammasome depends on dual signals: the priming signal, such as the toll-like receptor (TLR)/nuclear factor-kappaB (NF-κB) pathway, upregulates its expression, and subsequently, the activation signal, including K⁺ efflux, reactive oxygen species (ROS), and mtDNA release, promotes oligomerization and assembly, ultimately activating caspase-1 [35–37]. As a key DAMP sensor, NLRP3 engages in cross-talk regulation with the cGAS-STING pathway—cGAMP indirectly activates NLRP3 through the P2X7 receptor (P2X7R) ion channel, while caspase-1 cleavage of cGAS establishes a negative feedback loop [38, 39] (Fig. 1). The AIM2 inflammasome The AIM2 inflammasome features an HIN domain that specifically binds cytosolic dsDNA, relieving autoinhibition of its PYD domain [40]. This allows recruitment of the ASC adaptor and activation of caspase-1, promoting IL-1β/IL-18 maturation and pyroptosis [41]. AIM2 expression correlates with autoimmune diseases and functionally interacts with cGAS-STING, as cGAMP can enhance AIM2 activation [42] (Fig. 1). MAVS RLR-MAVS signaling is the core mechanism of innate antiviral immunity. The cascade initiates when intracellular viral RNA is detected by the cytosolic pattern recognition receptors RIG-I and MDA5—first identified by Yoneyama et al. (2004–2005) as critical sensors frequently subverted by viral evasion factors like the nonstructural protein 3/4A (NS3/4A) protease [43, 44]. Upon activation, these receptors bind to the downstream adaptor MAVS, a milestone discovery by Seth et al. (2005) that established the outer mitochondrial membrane as an essential immunological hub for interferon induction [45]. The spatial complexity of this pathway was subsequently expanded when Dixit et al. (2010) identified peroxisomes as an alternative MAVS signaling platform [46]. Furthermore, Horner et al. (2011) refined the spatial dynamics of this network by revealing that MAVS is highly enriched at MAM, functioning as an "innate immune synapse" that is precisely targeted by viral evasion factors [47]. In the same year, Hou et al. elucidated the physical mechanism driving signal amplification, revealing that receptor binding induces MAVS to oligomerize into highly functional, prion-like structural scaffolds [30, 48]. Ultimately, these massive signalosomes recruit and activate downstream transcription factors, specifically NF-κB and IRF3 [45], which synergistically drive the robust expression of type I interferons (IFNs) and pro-inflammatory cytokines to mount a comprehensive antiviral immune response [49]. The cGAS-STING pathway and MAVS govern RNA- and DNA-triggered IFN responses, respectively. The NLRP3 and AIM2 inflammasomes mediate robust inflammatory cascades. Crucially, these pathways do not operate in isolation. Extensive cross-talk is orchestrated by second messengers, such as cGAMP, which synergistically amplify parallel immune signals. To prevent pathological overactivation, this network also engages reciprocal inhibitory mechanisms, such as the caspase-1-mediated cleavage of cGAS. Together, these dual mechanisms of activation and inhibition ensure a precisely calibrated innate immune response. Collectively, these pathways constitute a comprehensive intracellular nucleic acid surveillance network. MAM modulates innate immune responses MAM modulates innate immune responses through Ca2+ signaling Ca2+ is critically involved in modulating innate immunity via diverse mechanisms such as the induction of immunogenic cell death, autophagy in dendritic cells, T cell activation, and macrophage polarization [50]. The MAM serves as the structural basis for Ca2+ transfer from the ER to mitochondria, and dysregulation of its mediated Ca2+ transport is closely associated with the pathogenesis of various innate immune diseases [51, 52]. The IP3R-Grp75-VDAC complex directly regulates Ca2+ transfer from the ER to mitochondria [53]. The mitochondrial calcium uniporter (MCU) on the inner mitochondrial membrane is a key channel for Ca2+ entry into the mitochondrial matrix [54]. The Ca2+ signaling axis composed of IP3R, Grp75, VDAC1, and the MCU precisely regulates Ca2+ ion transfer from the ER to mitochondria, a process with profound implications for cellular metabolism, activation, and fate determination [55]. MCU forms functional channels through oligomerization, a mechanism inhibited by the specific inhibitor Ru360 [56]. Additionally, the VAPB-PTPIP51 complex influences Ca2+ exchange by regulating the distance between the ER and mitochondrial membranes [57]. Sigma-1 receptor (σ1R), functioning as a molecular chaperone on MAM, enhances Ca2+ transport efficiency by stabilizing IP3R3 under ER stress conditions [58]. In primary cortical neurons, casein kinase 2 alpha 1 (CK2A1) phosphorylates phosphofurin acidic cluster sorting protein 2 (PACS2) to promote the localization of the CK2A1-PACS2-polycystic kidney disease 2 (PKD2) complex at the MAM. This spatial regulation subsequently modulates PKD2-dependent mitochondrial Ca2+ influx [59]. Similarly, studies in the H9C2 cell line demonstrate that the transient receptor potential vanilloid 1 (TRPV1) ion channel actively participates in MAM Ca2+ homeostasis. The functional impairment of TRPV1 disrupts Ca2+ efflux, which is proposed to trigger oxidative stress and ultimately lead to the hypoxia/reoxygenation-induced cell death [60]. Ca2+/calmodulin-dependent protein kinase II (CaMKII)-mediated IP3R phosphorylation promotes ER Ca2+ release, activating the CaMKKβ-AMP-activated protein kinase (AMPK) pathway, which inhibits Unc-51 like autophagy activating kinase 1 (ULK1)-mediated autophagy. This reduces macrophage inflammatory cytokine secretion and bacterial clearance capacity [61] (Fig. 2). MAM-mediated calcium transport and its regulation of innate immunity. The calcium transport complex is composed of the inositol 1,4,5-trisphosphate receptor (IP3R) on the endoplasmic reticulum membrane, the chaperone glucose-regulated protein 75 (Grp75), and the voltage-dependent anion channel 1 (VDAC1) on the mitochondrial outer membrane. This complex facilitates the efficient transfer of Ca2+ from the endoplasmic reticulum to the mitochondrial intermembrane space. Subsequently, Ca2+ enters the mitochondrial matrix through the mitochondrial calcium uniporter (MCU) complex on the inner mitochondrial membrane. Dysfunction or structural disruption of MAM impairs Ca2+ transfer, leading to mitochondrial calcium overload. This results in the opening of the mitochondrial permeability transition pore (mPTP), leakage of mtDNA into the cytoplasm, and subsequent activation of the innate immune response. The image was generated with full licensed BioRender.com The dysregulated expression of functional complexes or aberrant intermembrane tethering at the MAM axis disrupts the Ca2+ flux balance between the ER and mitochondria. This dyshomeostasis frequently precipitates mitochondrial Ca2+ overload and ER stress, which are strongly associated with the subsequent activation of innate immune signaling. For instance, in chronic social defeat stress (CSDS) models, stress reinforces microglial MAM via the P2X7 receptor-eATP pathway. This structural remodeling is proposed to drive Ca2+ overload and mitochondrial impairment through the IP3R3-GRP75-VDAC1 complex, a process that correlates with the hyperactivation of the NLRP3 inflammasome and the emergence of depression-like behaviors [62]. In sheep hepatocytes, molybdenum (Mo) and cadmium (Cd) disrupt MAM integrity and upregulate this IP3R-mediated complex. The ensuing Ca2+ overload acts as a critical upstream signal that facilitates the activation of the NLRP3 inflammasome, a pathological cascade effectively reversed by the IP3R inhibitor 2-APB [63]. Conversely, therapeutic interventions can restore MAM calcium homeostasis to dampen immune overactivation. In the intestine of piglets, the natural compound hesperidin suppresses deoxynivalenol (DON)-induced excessive MAM formation and downregulates the IP3R-GRP75-VDAC1-MCU signaling axis, which appears to subsequently alleviate oxidative stress and ferroptosis, thereby contributing to improved mitochondrial function [64]. Beyond calcium channels, MAM-resident tethering proteins directly modulate immune signaling. VAPB acts as a negative regulator of STING by binding its C-terminal transmembrane domain, which restricts STING ER-to-Golgi trafficking and TBK1 recruitment. In contrast, the amyotrophic lateral sclerosis (ALS)-associated mutant VAPB P56S forms intracellular inclusions that aberrantly activate STING signaling under resting conditions [65]. MAM modulates innate immune responses through lipid transfer Phosphatidylserine (PS) synthesized in the ER requires trafficking via MAM to mitochondria for the generation of phosphatidylethanolamine (PE), and the enrichment of cholesterol at MAM is crucial for its structural integrity [66, 67]. Among the oxysterol-binding protein (ORP) family proteins, ORP5/8 transports PS from the ER to MAM through VAP-mediated channels [68]. Their oxysterol-binding protein-related domain (ORD) delivers PS to mitochondrial membranes. This facilitates PS-to-PE conversion, a process critical for sustaining mitochondrial function [68]. ORP5/8 knockdown in HeLa cells induces an abnormal accumulation of plasma membrane phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P2) levels [11]. Concurrently, it hinders the transport of PS from the ER to mitochondria, resulting in decreased mitochondrial PE synthesis [68]. Ultimately, this lipid deficit disrupts cristae architecture and respiratory function [69]. Overexpression of ORP8 ameliorates hepatic lipid accumulation in diet-induced obese mice [70]. This lipid axis is critically involved in modulating immune receptor signaling. The PS distribution abnormality has been shown to impair the ligand-binding capacity of the triggering receptor expressed on myeloid cells 2 (TREM2), hindering activation of the downstream DNAX-activating protein of 12 kDa (DAP12)-spleen tyrosine kinase (SYK) signaling pathway and subsequently leading to defective NLRP3 inflammasome activation [71]. Phosphatidylserine decarboxylase 1 (Psd1) converts PS to PE, and mutations lead to mitochondrial PE deficiency and cristae structure abnormalities [72]. Therefore, the MAM-mediated PS-PE axis becomes essential for the innate immune response through dual mechanisms: maintaining mitochondrial structural integrity to prevent the leakage of pro-inflammatory danger signals, and ensuring proper cellular lipid distribution to license immune receptor activation (Fig. 3). MAM-mediated lipid transport and its regulation of innate immunity. MAM precisely regulates the molecular mechanisms of innate immune responses by mediating the metabolism and transport of phospholipids and cholesterol. Oxysterol-binding protein 5 and 8 (ORP5/8) mediate the transport of phosphatidylserine (PS) from the endoplasmic reticulum to mitochondria. Loss of ORP5/8 function disrupts PS distribution, thereby impairing the activation of innate immune responses. Acyl-CoA:cholesterol acyltransferase 1 (ACAT1) catalyzes the esterification of free cholesterol (FC) into cholesteryl esters (CE), which is stored in lipid droplets. Deficiency in ACAT1 leads to the accumulation of FC in the endoplasmic reticulum, triggering ER stress and subsequently activating innate immune responses via pathways such as the inflammasome. The image was generated with full licensed BioRender.com MAM serves as a spatial scaffold for innate immune signaling molecules. Studies suggest that in yeast, the human innate immune adaptor protein myeloid differentiation primary response 88 (MyD88) specifically localizes to MAM, indicating that MAM may participate in the pre-assembly or regulation of the myddosome complex during TLR signaling; co-expression of the TLR4 intracellular toll interleukin-1 receptor (TIR) domain further drives the formation of a functional complex between MyD88 and plasma membrane-localized TIR-containing adaptor protein (TIRAP) [73]. In breast cancer models, MAM acts as a pivotal platform that facilitates ferroptosis by enriching polyunsaturated fatty acid phospholipids and promoting their peroxidation, which is associated with mechanisms of tumor immune escape [74]. Furthermore, studies in Ctenopharyngodon idellus kidney cells reveal that MAM-localized diacylglycerol O-acyltransferase 2 (DGAT2) catalyzes triglyceride synthesis to form specific lipid droplets (LDs). This structural formation is proposed to provide a regulatory platform for the MyD88-IRF7/NF-κB signaling cascade in TLR7-mediated pathways [75]. Dysregulated cholesterol metabolism at MAM regions serves as a core trigger for excessive inflammatory responses. Oxysterol binding protein (OSBP) regulates cholesterol transport, affecting mitochondrial membrane fluidity [76]. Acyl-CoA cholesterol acyltransferase 1 (ACAT1) leads to the accumulation of free cholesterol (FC) within macrophages, promoting the formation of DAMPs such as cholesterol crystals (CCs), which subsequently induce ER stress and the release of pro-inflammatory cytokines [77]. Furthermore, cholesterol crystals or lipid peroxidation products directly provoke ER stress, which facilitates the release of mitochondrial DAMPs (mtDAMPs)—including mitochondrial reactive oxygen species (mtROS) and mtDNA—via the inositol-requiring enzyme 1 alpha (IRE1α)– thioredoxin interacting protein (TXNIP) signaling axis, thereby activating the NLRP3 inflammasome [78, 79]. Notably, mtDAMPs released upon mitochondrial injury participate in the formation of the MAVS complex or directly activate the NLRP3 inflammasome [45, 80, 81] (Fig. 3). MAM modulates innate immune responses through mitochondrial dynamics MAM acts as a spatial scaffold to integrate mitochondrial dynamics. Specifically, ER tubules at MAMs mark fission sites by recruiting dynamin-related protein 1 (DRP1), while MAM-resident proteins like MFN2 mediate fusion [82, 83]. By organizing these opposing proteins, MAM plays a critical role in regulating overall mitochondrial morphology, thereby indirectly modulating downstream innate immune responses [84]. Mitochondrial fusion is primarily mediated by the outer membrane proteins MFN1/2 and the inner membrane protein optic atrophy 1 (OPA1). While OPA1 is responsible for inner membrane fusion and maintaining cristae structure [85], MFN2 facilitates outer membrane fusion by tethering adjacent mitochondria via its heptad repeat 2 (HR2) domain [86]. Crucially, mitochondrial dynamics are intricately linked to calcium signaling via MAM regulation. MFN2 reinforces endoplasmic reticulum-mitochondria tethering to enhance cellular calcium buffering capacity. This enhanced buffering has been shown to suppress the nuclear translocation and transcriptional activity of nuclear factor of activated T cells (NFAT), ultimately preserving the lymphoid differentiation potential of hematopoietic stem cells [87]. Furthermore, the tight coupling of mitochondrial dynamics to calcium flux is closely associated with inflammatory cascades. Downregulation of MFN2 disrupts MAM integrity, induces mitochondrial dysfunction, and contributes to cardiac hypertrophy [88]. In a rat model of lipopolysaccharide (LPS)-induced intestinal injury, Chimonanthus nitens Oliv. essential oil has been demonstrated to reduce MAM formation by targeting MFN2. This mechanism strongly correlates with the suppression of NLRP3 inflammasome activity and IL-1β secretion, ultimately alleviating the intestinal damage [84]. Conversely, in models of ischemia/reperfusion (I/R)-induced kidney injury, restoring MFN2 expression has been shown to stabilize calcium homeostasis, a process that subsequently contributes to the attenuation of the inflammatory response [89]. MFN2 undergoes dynamic modifications. In a Drosophila genetic model, phosphorylation of MFN2 has been shown to stimulate Parkin-dependent mitochondrial fission and degradation. Conversely, its dephosphorylation by phosphoglycerate mutase 5 (PGAM5) promotes mitochondrial stability and network formation [90]. This dynamic regulation has significant immunological implications – physiologically, MFN2-promoted fusion enhances monocyte antibacterial function, while in pathological conditions like cholestasis, aberrant MFN2 activity is implicated in facilitating ER-MFN2-mediated Ca2+ overload and the subsequent activation of the NLRP3 inflammasome [91]. MFN2 binds to the C-terminal region of MAVS via its HR1 domain. This interaction drives the formation of macromolecular complexes, thereby suppressing the MAVS-mediated, RIG-I/MDA5-dependent antiviral signaling pathway [92] (Fig. 4). MAM regulates innate immunity through modulating mitochondrial dynamics. Mitochondrial fusion is mediated by the outer membrane proteins mitofusin 1/2 (MFN1/2) and the inner membrane protein optic atrophy 1 (OPA1), with MFN2 being localized to MAM. Mitochondrial fission is primarily driven by the cytosolic protein Drp1, which is recruited to the mitochondrial outer membrane and binds to receptor proteins including fission 1 protein (FIS1), mitochondrial fission factor (MFF), mitochondrial dynamics proteins of MiD49, and MiD51, thereby facilitating membrane constriction and fission. Downregulation of MFN2 disrupts MAM integrity, induces endoplasmic reticulum stress, and causes mitochondrial dysfunction, thereby activating innate immune responses. Conversely, upregulation of MFN2 promotes MAM formation and subsequently suppresses innate immunity. The image was generated with full licensed BioRender.com Mitochondrial fission is primarily governed by the cytosolic protein DRP1. DRP1 binds to receptor proteins on the mitochondrial outer membrane, such as mitochondrial fission 1 protein (FIS1), mitochondrial fission factor (MFF), mitochondrial dynamics proteins of MiD49 and MiD51, causing mitochondrial membrane constriction and fission [5, 93–95]. Fission is regulated by various factors. Under hypoxic conditions, the MAM protein FUN14 domain-containing protein 1 (FUNDC1) recruits DRP1 to drive fission [96]. Aberrant fission is closely linked to innate immune activation: environmental toxins. Di-(2-ethylhexyl) phthalate (DEHP) inhibits MFN2 and upregulates DRP1, disrupting MAM and inducing mitochondrial calcium overload and oxidative stress, ultimately leading to neuroinflammation [17]. Furthermore, imbalanced mitochondrial dynamics are proposed to trigger ER stress by physically uncoupling the MAM interface. Excessive mitochondrial fission disrupts stable ER-mitochondria tethering, thereby impairing inter-organelle calcium and lipid exchange. This functional disconnection leads to ER calcium dyshomeostasis and the accumulation of misfolded proteins, which are established activators of the ER stress response. In sheep heart models of cadmium/molybdenum exposure, enhanced fission disrupts MAM integrity. This structural disruption is associated with the activation of endoplasmic reticulum stress and autophagy pathways, ultimately exacerbating tissue damage [97] (Fig. 4). MAM modulates innate immune responses through mitochondrial protein modifications At the MAM, post-translational modifications (PTMs)—such as phosphorylation, ubiquitination, and acetylation—form an intricate network that dynamically controls core resident proteins. This PTM-driven regulation orchestrates mitochondrial calcium homeostasis, mtROS/mtDNA release, energy metabolism, dynamics, and quality control [98]. Ultimately, these coordinated modifications are proposed to profoundly influence the activity of innate immune pathways, including the NLRP3 inflammasome and cGAS-STING. Phosphorylation acts as a central hub connecting mitochondrial function to immune activation, influencing diverse immune-related events. The phosphorylation status of VDAC1 directly regulates its channel activity, impacting metabolite transport, mtROS generation, and mtDNA release [19, 99]. The low-dose checkpoint kinase 1 (CHK1) inhibitor prexasertib blocks the never in mitosis gene A-related kinase 1 (Nek1)-mediated phosphorylation of VDAC1 at Thr107. This blockade promotes VDAC1 oligomerization and induces the release of mtDNA into the cytosol. The resulting cytosolic mtDNA subsequently activates the cGAS-STING-TBK1-IRF3 pathway, triggering a type I interferon innate immune response [19]. Furthermore, during ferroptosis in cancer cells, Grp75 undergoes protein kinase A (PKA) phosphorylation at Ser148. Its translocation to the cytosol allows it to competitively bind Kelch-like ECH-associated protein 1 (Keap1), a direct interaction that subsequently contributes to the activation of the nuclear factor erythroid 2-related factor 2 (Nrf2) antioxidant pathway, thereby enhancing cellular stress resistance [100] (Fig. 5). MAM regulates mitochondrial function and innate immunity through mitochondrial protein modifications. The checkpoint kinase 1 (CHK1) inhibitor prexasertib, at low doses, blocks never in mitosis gene A related kinase 1 (Nek1)-mediated phosphorylation of VDAC1 at Thr107, promoting VDAC1 oligomerization and subsequent release of mtDNA into the cytoplasm, thereby triggering innate immune activation. In contrast, K27-linked polyubiquitination at K53 of VDAC1 inhibits its oligomerization, suppressing mtDNA release and downstream innate immune signaling. Additionally, deacetylation of ATPase family AAA domain-containing protein 3 A (ATAD3A) at K134 by the mitochondrial deacetylase SIRT3 promotes its oligomerization, prevents excessive binding to the IP3R1–Grp75–VDAC1 complex, and attenuates MAM overformation and calcium overload, ultimately inhibiting activation of the innate immune response. The image was generated with full licensed BioRender.com Complementing phosphorylation, ubiquitination exerts a dual regulatory role in the MAM by orchestrating immune signaling on one hand and maintaining mitochondrial quality control (MQC) on the other, thereby ensuring the timeliness and precision of immune responses. In liver fibrosis models, specific K27-linked polyubiquitination of VDAC1 at lysine 53 (K53) has been shown to inhibit VDAC1 oligomerization and effectively block mtDNA release, a mechanism that correlates with the prevention of cGAS-STING innate immune pathway hyperactivation [101]. Conversely, in Parkinson's disease models, the E3 ubiquitin ligase tripartite motif-containing protein 31 (TRIM31) promotes K48-linked polyubiquitination and proteasomal degradation of VDAC1, a targeted degradation process essential for maintaining mitochondrial functional homeostasis [102]. The mitochondrial E3 ubiquitin ligase MARCH5 dynamically regulates mitophagy by specifically targeting the receptor protein FUNDC1 for ubiquitination and degradation at K119 residue under hypoxic conditions [103]. Concurrently, in lipopolysaccharide (LPS)-treated RAW264.7 macrophages, MARCH5 ubiquitinates and degrades the mtDNA-activated DNA-dependent protein kinase catalytic subunit (DNA-PKcs). This targeted degradation is associated with the suppression of DNA-PKcs-heat shock protein A8 (HSPA8) axis-mediated type I interferon responses [104] (Fig. 5). Acetylation, particularly its reversible deacetylation, is a core mechanism for MAM to maintain mitochondrial homeostasis, suppress excessive inflammation, and regulate antiviral immunity. The mitochondrial deacetylase Sirtuin 3 (SIRT3) plays a pivotal role. In cardiac hypertrophy models, SIRT3 deacetylates K134 of ATAD3A to promote its oligomerization, which effectively blocks its excessive binding to the core ER-mitochondria Ca2+ transfer complex (IP3R1-GRP75-VDAC1). Ultimately, this intervention prevents aberrant MAM proliferation and the ensuing Ca2+overload [105]. Simultaneously, in dopaminergic neuronal cells, SIRT3 targets MCU and the key mitochondrial permeability transition pore (mPTP) component cyclophilin D (CypD). This interaction stabilizes mitochondrial Ca2+ homeostasis, which subsequently contributes to the synergistic inhibition of NLRP3 inflammasome activation [106] (Fig. 5). MAM modulates innate immune responses through autophagy Autophagy is a core process for maintaining cellular homeostasis [107]. By clearing damaged organelles and protein aggregates, it plays a dual role in regulating innate immunity [108]. The MAM, serving as a dynamic platform connecting ER and mitochondria, is widely recognized as a critical site for autophagosome formation. Under energy stress, the core autophagy complexes autophagy related 14 (ATG14) complex and ATG5 specifically accumulate on MAM, a process dependent on key anchoring proteins phosphofurin acidic cluster sorting protein-2 (PACS-2) and MFN2 [109]. MAM harbors lipid rafts enriched in cholesterol and ganglioside GD3, which recruit autophagy initiation factors to drive autophagosome formation, which can be inhibited by knockout of GD3 synthase ST8SIA1 [110]. MAM also integrates Ca2+ signaling and energy sensing. For instance, in hepatocellular carcinoma (HCC) treated with high-dose metformin (MetF), disruption of the VDAC1 channel elevates cytosolic Ca2+ levels, which activates the AMPK pathway and subsequently induces autophagy [111]. Under energy stress in HeLa cells, activated AMPK translocates to the MAM and directly interacts with MFN2 to facilitate mitochondrial fission and autophagy [112]. Additionally, this energy-sensing cascade also triggers the direct downstream effector of AMPK, Unc-51 like autophagy activating kinase 1 (ULK1), to initiate targeted mitochondrial clearance. ULK1 phosphorylates FUNDC1 at Ser-17, a mitochondrial receptor, to promote mitophagy [113] (Fig. 6). MAM-mediated autophagy regulates innate immunity. Autophagy suppresses excessive inflammatory responses by clearing DAMPs and overactivated NLRP3 inflammasome components. However, multiple pathogen proteins exploit the ubiquitin-autophagy pathway to degrade immune signaling molecules, thereby reducing mtDNA leakage and inhibiting cGAS–STING pathway activation, which ultimately attenuates type I interferon production. During autophagy initiation, damaged mitochondria recruit autophagy initiation factors AMBRA1 and Beclin1 via lipid rafts enriched in MAM. Concurrently, the (PTEN)-induced kinase 1 (PINK1)-Parkin pathway is activated, promoting autophagosome formation. For autophagosome formation, core autophagy machinery components such as ATG5-ATG12-ATG16L1 assemble at MAM sites to encapsulate damaged organelles. Finally, autophagosomes fuse with lysosomes to form autolysosomes, where the contents are degraded. The image was generated with full licensed BioRender.com MAM-mediated autophagy is recognized to profoundly modulate innate immune responses through dual regulatory pathways. On one hand, autophagy suppresses excessive inflammation by clearing DAMPs and selectively degrading overactivated NLRP3 inflammasome components ("precision autophagy") [114]. On the other hand, dysregulated autophagy or its exploitation by pathogens can lead to immunosuppression, primarily through selective degradation of key immune signaling molecules. In peritoneal mesothelial cells, Beclin 1 mediates autophagosome membrane extension by regulating the class III phosphatidylinositol 3-kinase catalytic subunit type 3 (VPS34) complex on the MAM. This regulatory process subsequently contributes to the inhibition of excessive NLRP3 inflammasome activation triggered by mitochondrial damage [115]. The alpha-herpesvirus unique long region 21 (UL21) protein promotes cGAS degradation via ubiquitin protein ligase E3C (UBE3C)-mediated K384 ubiquitination and toll interacting protein (TOLLIP) receptor recognition, inhibiting type I IFN [116]. Avibirnavirus VP3 protein degrades TNF receptor associated factor 6 (TRAF6) via sequestosome 1 (SQSTM1/p62)-dependent autophagy, inhibiting NF-κB and IFN-β [117]. Influenza A virus PB1-F2 physically binds to Tu translation elongation factor (TUFM) and LC3B via its LIR motif; this molecular interaction is proposed to trigger aberrant mitophagy, ultimately leading to the degradation of MAVS and the subsequent suppression of IFN production [118]. The deubiquitinase ubiquitin specific peptidase 19 (USP19) recognizes a KFERQ-like motif on TBK1, upregulating HSPA8 and lysosomal-associated membrane protein 2 A (LAMP2A) to mediate its degradation via chaperone-mediated autophagy (CMA), inhibiting IRF3 activation and IFN-β [119]. Mitophagy itself is a critical immunoregulatory node. PTEN-induced kinase 1 (PINK1)-mediated mitophagy clears damaged mitochondria, effectively reducing the leakage of mtDNA into the cytosol and thereby contributing to the suppression of cGAS-STING pathway-mediated type I IFN inflammation [120]. Furthermore, PINK1/Parkin-mediated mitophagy has been implicated in the inhibition of MAVS oligomerization and STING translocation, aiding pathogen immune evasion [121]. Conversely, F-box and leucine-rich repeat protein 4 (FBXL4) maintains homeostasis by degrading mitophagy receptors NIX/BNIP3 via the SKP1-CUL1-F-box protein complex [122]. In terms of intrinsic feedback regulation, STING promotes autophagosome formation by directly recruiting WD repeat domain, phosphoinositide interacting 2 (WIPI2). This direct recruitment drives non-canonical autophagy induced by the cGAS–STING pathway, which subsequently facilitates cytoplasmic DNA clearance and modulates immune responses [123]. Furthermore, through its LIR domain, STING directly triggers ATG5-dependent non-canonical autophagy, which not only activates the innate immune response but also mediates the degradation of both itself and phosphorylated TBK1 via the autophagic pathway, thereby establishing a negative feedback loop to proposed to fine-tune immune activation [124] (Fig. 6). Innate immune-related diseases mediated by MAM Dysregulation The dysregulation of MAM-mediated innate immunity critically contributes to the pathogenesis and progression of a broad spectrum of innate immune-mediated disorders, notably neurodegenerative diseases [125], cardiovascular diseases [126], and diabetes [127]. Neurodegenerative diseases In Alzheimer's disease (AD), the precise physical architecture of the MAM dictates immune-pathological outcomes. Hyper-tethered MAMs (~ 6 nm gap) accelerate Aβ production and restrict axonal mitochondrial transport [128]. The resulting Aβ accumulation acts as a potent DAMP, priming microglial innate immune sensors. Reversing this aberrant tethering using Tacedinaline (Tac), an HDAC inhibitor, shortens MAM contacts, alleviates Ca2+ overload, and restores mitochondrial polarization [129], thereby quenching the upstream triggers of cGAS-STING and NLRP3-mediated neuroinflammation. Conversely, in amyotrophic lateral sclerosis (ALS), genetic lesions like the VAPB P56S mutation disrupt MAM integrity, sensitizing motor neurons to ER stress and elevating ATF4, a core integrated stress response (ISR) regulator [130]. This sustained ISR acts as an early sterile inflammatory signal. Furthermore, this structural uncoupling forces a maladaptive metabolic shift from glucose to fatty acid oxidation, altering Complex I electron flow [131]. The resulting oxidative stress and mtDNA leakage persistently activate PRRs, driving aberrant microglial activation and rapid motor neuron apoptosis.. Cardiovascular diseases In pathologies like cardiac hypertrophy and myocardial infarction/reperfusion (MI/R) injury, MAM structural collapse catalyzes sterile cardiac inflammation. Specifically, the depletion of crucial MAM-resident scaffolds—such as FMO2 and Fbxo7-stabilized Mtus1A —disrupts the core IP3R-Grp75-VDAC1 Ca2+-channeling complexes [13, 132]. This decoupling precipitates bioenergetic failure and exacerbates pathological cardiac remodeling. Crucially, stabilizing this interface can quench downstream innate immune triggers. For instance, thymoquinone (TQ) directly binds the L368 residue of the MAM stabilizer ATAD3A, preserving its interaction with PERK during MI/R [133]. This targeted structural rescue attenuates ER stress, neutralizes ROS, and prevents mtDNA leakage. By hermetically sealing the mitochondria and preventing the cytosolic release of these potent DAMPs, such MAM-stabilizing strategies effectively cut off the upstream activation of innate immune cascades (e.g., cGAS-STING), mitigating cardiomyocyte apoptosis. Diabetic nephropathy Under glucolipotoxic stress, aberrant MAM remodeling serves as a central hub for sterile inflammation across diabetic target organs. In pancreatic β-cells, lipid-induced PDZD8 upregulation expands MAM interfaces, promoting VDAC1-GRP75-IP3R1 assembly and CypD-mediated Ca2+ overload. Knocking down PDZD8 shortens these structural contacts, effectively blocking pathological Ca2+ flux and blunting downstream metabolic inflammation [134]. In diabetic nephropathy (DN), MAM dysfunction tightly couples organelle stress to immunogenic cell death. Specifically, CNPY2 activates the MAM-associated PERK/ATF4/CHAC1 pathway to drive ferroptosis, releasing potent danger signals that amplify sterile renal inflammation [135]. Conversely, restoring MAM integrity via vitamin D receptor (VDR) activation reinstates Mfn2-Fundc1-mediated mitophagy. This structural rescue suppresses mtROS generation, effectively clearing innate immune triggers (DAMPs) to mitigate tubulointerstitial fibrosis [136]. Furthermore, this hyperglycemia-induced MAM hyper-assembly extends to the central nervous system, seeding neuroinflammation. However, genetically upregulating SIRT3 actively dissociates the core VDAC1-GRP75-IP3R complex. This restricts abnormal MAM proliferation, thereby alleviating diabetes-induced neurocognitive dysfunction [137]. Concluding remarks MAM serves as a hub for spatiotemporal intracellular signaling communication, and its structure and function are critical for regulating innate immune responses, including those mediated by AIM2, NLRP3, and the cGAS–STING pathway. However, there is currently no direct evidence indicating that the MAM structure itself acts as a signaling platform that directly recruits or activates innate immune molecules. A central unresolved question remains: Is the MAM a preformed, active signaling platform capable of directly recruiting and specifically activating these innate immune molecules? Or does it primarily function passively by creating spatial proximity and supplying essential cofactors—such as a specific lipid environment or high-calcium microdomains—to facilitate intermolecular interactions and complex assembly? Resolving this question is pivotal for understanding how immune signals are precisely compartmentalized and regulated at sub-organellar interfaces (Fig. 7). Unresolved scientific issues in MAM-mediated regulation of innate immunity. The MAM serves as a critical subcellular platform for the regulation of intracellular innate immune signaling. This figure sequentially illustrates four outstanding scientific questions in this field: (1) Does the MAM directly recruit and specifically activate key innate immune sensors, such as the absent in melanoma 2 (AIM2) and NLRP3 inflammasomes, as well as cyclic GMP-AMP synthase (cGAS)? (2) Can the MAM establish specific lipid environments or high-Ca2+ microdomains—enriched in phosphatidylserine (PS), phosphatidylethanolamine (PE), and cardiolipin (CL)—to facilitate immune complex assembly via spatial proximity? (3) Under pathological conditions, does the VDAC-Grp75-IP3R complex increase mitochondrial membrane permeability to facilitate the release of DAMPs (e.g., mtDNA)? Furthermore, within the MAM, does mtDNA exhibit enhanced binding affinity for cGAS to subsequently drive cGAMP synthesis and STING phosphorylation? (4) Can CL, released via lipid transporters (e.g., VPS13A) or direct diffusion, reach the ER membrane to bind and activate NLRP3 that is either resident or newly recruited to the MAM? The image was generated with full licensed BioRender.com Under physiological conditions, a moderate increase in MAM promotes interorganellar communication and coordination. Under pathological conditions such as immune dysregulation, MAM frequently undergoes an increase in formation or structural remodeling. The VDAC/Grp75/IP3R complex is classically known to regulate calcium homeostasis and phospholipid transport [13], but under pathological conditions, does it directly contribute to or induce pathological increases in mitochondrial membrane permeability—particularly the release of DAMPs such as mtDNA? Furthermore, given that MAM physically links mitochondria (the source of mtDNA) and the endoplasmic reticulum (where STING is localized), is released mtDNA preferentially sensed in this compartment by cGAS to initiate downstream signaling? Do the specific lipids and anchor proteins enriched at MAM collectively form a unique microenvironment that promotes efficient cGAS binding to mtDNA, synthesis of cGAMP, and activation of neighboring STING? Does MAM constitute a “hotspot” that enhances this process compared with non-MAM regions? Are there specific regulatory cofactors on MAM that facilitate this activation? (Fig. 7). Mitochondrial stress—such as loss of membrane potential or outer membrane permeabilization—can lead to the release of inner membrane components or matrix contents (including mtDNA and tricarboxylic acid cycle metabolites) into the cytoplasm [138, 139]. How do immune-related receptors or sensors located on the ER perceive these diffusible and heterogeneous mitochondrial DAMPs in the cytosol? Does this sensing directly trigger active remodeling of MAM structures, such as contact area expansion and recruitment of specific proteins, thereby efficiently transmitting and amplifying these 'danger signals' from mitochondrial damage sites? For example, can released cardiolipin—via lipid transporters such as VPS13A or through direct diffusion—reach the ER membrane, where it binds to and activates NLRP3 that is either resident or recruited to MAM? (Fig. 7). Deeply elucidating the immunoregulatory role of MAM urgently requires the integration of cutting-edge technologies. First, developing in situ dynamic imaging techniques—such as live-cell cryo-electron tomography and correlative light-electron microscopy—is essential to observe MAM structures and interactions in real time. Furthermore, multi-omics approaches must be integrated to construct a comprehensive molecular map of the MAM. Finally, combining MAM fractionation with omics analysis will be crucial. This approach can reveal whether mtDNA and other DAMPs achieve signal-directed delivery by targeting specific MAM proteins during immune dysregulation. In summary, MAM plays a crucial role in pathological processes related to immunodysregulation. Exploring therapeutic strategies for targeted regulation of MAM holds promise for providing new therapeutic targets and theoretical bases for immunodysregulation and related diseases. Acknowledgements Not applicable. Abbreviations Acyl-CoA cholesterol acyltransferase 1 Amyloid-β Alzheimer’s disease Absent in melanoma 2 Amyotrophic lateral sclerosis Acute myocardial infarction AMP-activated protein kinase Apoptosis-associated speck-like protein containing a CARD ATPase family AAA domain-containing protein 3A Autophagy related 14 Calcium ion Ca2+/calmodulin-dependent protein kinase II Ca2+/calmodulin-dependent protein kinase kinase β Cyclic GMP-AMP synthase Cholesterol crystals Checkpoint kinase 1 Casein kinase 2 alpha 1 Chaperone-mediated autophagy Cyclophilin D DNAX-activating protein of 12 kDa Damage-associated molecular pattern Di-(2-ethylhexyl) phthalate Diacylglycerol O-acyltransferase 2 DNA-dependent protein kinase catalytic subunit Dynamin-related protein 1 Double-stranded DNA Endoplasmic reticulum Endoplasmic reticulum stress Free cholesterol F-box and leucine-rich repeat protein 4 Mitochondrial fission 1 protein FUN14 domain-containing protein 1 Ganglioside D3 Glucose-regulated protein 75 Heptad repeat 2 Heat shock protein A8 Interferon Interleukin-1β Interleukin-18 Inositol 1,4,5-trisphosphate receptor Inositol-requiring enzyme 1 alpha Interferon regulatory factor 3 Ischemia/reperfusion Kelch-like ECH-associated protein 1 Lysine 53 Lysosomal-associated membrane protein 2A Microtubule-associated proteins 1A/1B light chain 3B Lipid droplets Lipopolysaccharide LC3-interacting region Mitochondria-associated endoplasmic reticulum membrane Mitochondrial antiviral signaling protein Membrane-associated RING-CH 5 Mitochondrial calcium uniporter Mitochondrial fission factor Mitofusin ½ Mitochondrial dynamics protein of 49 kDa Mitochondrial dynamics protein of 51 kDa Mitochondrial permeability transition pore Mitochondrial DAMPs Mitochondrial DNA Mitochondrial reactive oxygen species Myeloid differentiation primary response 88 Never in mitosis gene A related kinase 1 Nuclear factor of activated T cells Nuclear factor-kappaB Nucleotide-binding domain leucine-rich repeat and pyrin domain-containing protein 3 Mitophagy receptors NIX and BNIP3 Nuclear respiratory factor-1 Outer mitochondrial membrane Optic atrophy 1 Oxysterol-binding protein-related protein 5/8 Oxysterol-binding protein-related domain Oxysterol binding protein P2X7 receptor Phosphofurin acidic cluster sorting protein-2 Pathogen-associated molecular patterns Phosphatidylethanolamine Phosphoglycerate mutase 5 Protein kinase A Pattern recognition receptors Phosphatidylethanolamine decarboxylase 1 PTEN-induced kinase 1 Phosphatidylinositol-4,5-bisphosphate Protein tyrosine phosphatase interacting protein 51 Post-translational modifications Phosphatidylserine Reactive oxygen species Sequestosome 1 Sirtuin 3 Stimulator of interferon genes Spleen tyrosine kinase Sigma-1 receptor TANK-binding protein kinase 1 Transcription factor EB Toll interleukin-1 receptor TIR-containing adaptor protein Toll-like receptor Toll interacting protein TNF receptor associated factor 6 Tripartite motif-containing protein 31 Transient receptor potential vanilloid 1 Triggering receptor expressed on myeloid cells 2 Tu translation elongation factor Thioredoxin interacting protein Ubiquitin protein ligase E3C Unique long region 21 Unc-51 like autophagy activating kinase 1 Unfolded protein response Ubiquitin specific peptidase 19 Vesicle-associated membrane protein-associated protein B Voltage-dependent anion channel 1 Class III phosphatidylinositol 3-kinase catalytic subunit type 3 WD repeat domain, phosphoinositide interacting 2 Authors’ contributions QQZ, JYG, YTY and PG contributed equally. QQZ and JYG wrote the first draft of the manuscript and revised the manuscript. QQZ, JYG, PG and YTY created the figures and the graphical abstract. HL and YZZ conceptualized and supervised the review composition. SLZ, GXX, YTH, SYZ, HQG and YPS reviewed and edited the manuscript. All authors have read and approved the final manuscript. Funding This project is supported by the National Natural Science Foundation of China (No. 32570888, 32300629, 82230009, and 82430016), Natural Science Foundation of Henan (252300421145), Young and Middle-aged Health Science and Technology Innovation Talent Program of Henan Province (YQRC2025020), Postgraduate Education Reform and Quality Improvement Project of Henan Province (YJS2026SZKC24),the China Postdoctoral Science Foundation (Certificate Number: 2024M760772). Data availability No datasets were generated or analysed during the current study. Declarations Ethics approval and consent to participate Not applicable. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Qingqi Zhang, Junyan Gao, Yiting Yang and Ping Guo should be considered joint first author. Contributor Information Hao Liu, Email: haoliu_hdhh@henu.edu.cn. Yunzeng Zou, Email: zou.yunzeng@zs-hospital.sh.cn. References Associated Data Data Availability Statement No datasets were generated or analysed during the current study.